Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonist.
Maruyama Y, Ohsawa Y, Suzuki T, Yamauchi Y, Ohno K, Inoue H, Yamamoto A, Hayashi M, Okuhara Y, Muramatsu W, Namiki K, Hagiwara N, Miyauchi M, Miyao T, Ishikawa T, Horie K, Hayama M, Akiyama N, Hirokawa T, Akiyama T.
Maruyama Y, et al. Among authors: miyao t.
Nat Commun. 2024 Jul 19;15(1):5743. doi: 10.1038/s41467-024-49893-8.
Nat Commun. 2024.
PMID: 39030171
Free PMC article.